Table 2.
Two- and five-year survival rates according to type of variant tumor.
| Variant | Overall survival 2 years/5 years |
Disease-specific survival 2 years/5 years |
Progression-free survivala 2 years/5 years |
Recurrence-free survival 2 years/5 years |
|---|---|---|---|---|
| Micropapillary | 75%/0% | 69.8%/69.8% | 69.8%/69.8% | 61.1%/50.9% |
| Squamous | 92.3%/79.1% | 65.3%/43.5% | 65.2%/43.5% | 66.1%/44.1% |
| Nested | 100%/0.80% | 100%/75% | 83.3%/50% | 71.4%/23.8% |
| Glandular | 100%/83.3% | 100%/100% | 100%/100% | 100%/66.7% |
| Totala | 92.5%/66% | 85.6%/73.4% | 85.6%/60% | 72.3%/63.5% |
aTo stage ≥T2.